top of page
Pink Poppy Flowers

Iraqi and Arab Board Students Meeting

31st October 2026

 

This meeting was a medical case discussion session focused on reviewing clinical presentations and management approaches for various nephrology cases.

The participants discussed several complex cases including a patient with stage 5 chronic kidney disease who developed pleuroperitoneal dialysate leakage, requiring chest X-ray and contrast-enhanced imaging for diagnosis, followed by management with hemodialysis and chemical pleurodesis and this case was presented by Dr. Ridha Alshawy under supervision of Dr. Hasanain AlKhammas.

Dr. Mustafa AlMoula ( supervised by Dr. Mohammed Sami ) presented a comprehensive overview of sodium disorders, covering physiological regulation, classification of hyponatremia and hypernatremia, and clinical management approaches.

The group also discussed hepatorenal syndrome cases, including diagnostic approaches and treatment strategies with vasoconstrictor therapy and albumin administration. Throughout the session, participants provided differential diagnoses, discussed diagnostic workups, and shared clinical experiences in managing patients with advanced renal disease and complications.

Hepatorenal Syndrome with pathophysiology and treatment clinical cases discussion ( MCQs ).

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr Saja, Dr. Hasanain Alkhammas, Dr. Hayder Aledan, Dr.Alaa Abbas , Dr. Dua’a Knehir (Organizer), Dr.Mohammad Sami, Dr. Taman Mahdi, Dr. Dlnya Asad , Dr. Mustafa Abdullah, Dr.Noor Sadiq, Dr. Hayder hasan, Dr. Hassan Al-Fatlawi, Dr. Abdullah Touma, Dr.Sana Othman, Dr. Mohammed Aqeel, , Duaa Nabeel Abduljalel, Wael Mohan, Iman Naeem, Dr. Sima Salar, Dr. Noor Mazin, Dr. Ali wafi, Dr. Khoshe, Dr. Athal Jassem, Dr. Sagvan Kocher,Dr. Ahmed Lattif,Dr.  Duaa Nabeel, Dr.Jasem Saloom, Dr. Ridha Alshawy

 

 

 

24th October 2026

 

The meeting focused on a medical case review and educational discussion supervised by Proffesor Ihsan AlShamaa, regarding monoclonal immunoglobulin-associated kidney diseases.

Dr. Alaa Abbas and Dr.Duaa Knehir presented several pathology cases, including AL amyloidosis, light chain crystalline proximal tubulopathy, and monoclonal immunoglobulin deposition disease (MIDD), while explaining the diagnostic criteria and the role of kidney biopsy.

The group discussed the use of daratumumab in treating AL amyloidosis and reviewed the differences between various types of monoclonal-related kidney lesions.

The session also included a series of clinical vignettes and multiple-choice questions covering topics such as guideline-directed medical therapy in heart failure, the use of spot urine sodium for diuretic titration, and the differential diagnosis of acute kidney injury in patients with cirrhosis.

Pulmonary Pressure Monitoring and Diuretics Clinical Case Discussion.

Hepatorenal Syndrome Clinical Case Discussion.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr Saja, Dr. Hasanain Alkhammas, Dr. Hayder Aledan, Dr.Alaa Abbas , Dr. Ibraheem Assi, Dr. Dua’a Knehir (Organizer), Dr. Mohammad Sami, Dr. Taman Mahdi, Dr. Dlnya Asad , Dr. Mustafa Abdullah, Dr.Noor Sadiq, Dr. Hayder hasan, Dr. Hassan Al-Fatlawi, Dr. Abdullah Touma , Dr. Almustafa M Sultan, Dr. Sana Othman, Dr. Mohammed Aqeel, Dr. Ridha Alshawy, Dr. Duaa Nabeel Abduljalel, Dr. Wael Mohan, Dr. Iman Naeem, Dr. Sima Salar, Dr. Ahrar Ghanim, د. زهراء محمدعلي, Dr. Noor Mazin, Dr. Ali wafi, Dr. Khoshe

 

 

 

 

17th October  2026

 

 

The meeting focused on a medical presentation by Dr.Duaa Knehir regarding cardiorenal and hepatorenal syndromes, followed by a review of related clinical cases.

Dr.Duaa explained the pathophysiology of cardiorenal syndrome, including arterial underfilling and venous congestion mechanisms, and discussed pharmacological treatments such as MRAs and GLP-1 agonists.

She also covered strategies for diuretic-resistant heart failure, including the use of acetazolamide and thiazides, and reviewed novel devices and pharmacological targets.

The discussion then shifted to hepatorenal syndrome, where Dr.Duaa detailed its pathophysiology, diagnostic criteria, and the role of vasoconstrictors like terlipressin and albumin.

The group reviewed several case studies, including a patient with sepsis-associated AKI, the use of biomarkers for AKI risk stratification, and the management of diuretic resistance in heart failure. Participants, discussed the clinical application of these findings, the role of urine parameters in diagnosis, and the use of GLP-1 agonists in obese patients. The session concluded with a brief mention of rapidly progressive GN and dialytic treatment in critical illness.

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Saja, Dr. Hasanain Alkhammas, Dr. Hayder Aledan, Dr.Alaa Abbas , Dr. Dua’a Knehir (Organizer), Dr. Ibraheem Assi , Dr. Taman Mahdi, Dr. Dlnya Asad , Dr. Mustafa Abdullah, Dr. Hayder hasan, Dr. Hassan Al-Fatlawi, Dr. Abdullah Touma , Dr. Almustafa M Sultan, Dr. Sana Othman, Dr. Mohammed Aqeel, Dr. Ridha Alshawy, Dr. Duaa Nabeel Abduljalel, Dr. Wael Mohan, Dr.Iman Naeem, Dr. Sima Salar, Dr. Ahrar Ghanim

 

 

 

 

1st October 2026

 

The meeting focused on a comprehensive review of acute kidney injury (AKI) and critical care nephrology, based on Volume 25, Number 2 of the Nephrology Self-Assessment.

Dr. Duaa Knehir presented the editorial and key chapters, highlighting that AKI is a heterogeneous syndrome with evolving definitions and diagnostic criteria.

The discussion covered the limitations of serum creatinine, the role of novel biomarkers like NGAL and TIMP2 in identifying subclinical AKI, and the importance of personalized fluid and vasopressor strategies.

 

The group reviewed the KDIGO staging system, which integrates functional criteria with biomarker data to categorize AKI into stages 1A through 3B. They also discussed the long-term implications of AKI, including its association with chronic kidney disease, end-stage kidney disease, and cardiovascular complications.

 

Several case-based questions were analyzed to apply these concepts, including scenarios involving post-operative AKI, permissive AKI in heart failure, and the impact of administrative coding on AKI incidence data.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Hayder Aledan, Dr.Alaa Abbas , Dr. Dua’a Knehir (Organizer), Dr. Taman Mahdi, Dr. Dlnya Asad , Dr. Mustafa Abdullah, Dr.Noor Sadiq, Dr. Khoshe, Dr. Hayder hasan, Dr. Hassan Al-Fatlawi, Dr. Abdullah Touma , Dr. Almustafa M Sultan, Dr. Sana Othman

 

 

 

26th September 2026

 

This meeting was a clinical case presentation and discussion focused on a 19-year-old patient with IgA vasculitis nephritis.

Dr. Duaa Knehir presented the case details ( Supervised by Dr. Mohammed Y. AlAtbi ), including the patient's symptoms of abdominal pain, rash, and hematuria, along with laboratory findings showing proteinuria,hematuria. The team reviewed the patient's investigations and renal biopsy results, which showed IgA and C3 dominant deposits, consistent with IgA nephropathy.

 

Dr. Alaa Abbas provided detailed pathological analysis of the biopsy specimens, explaining the findings of mesangial expansion, endocapillary proliferation, and fibrocellular crescents.

 

The group discussed the clinical presentation, which appeared more severe than typical for IgA nephropathy, particularly given the patient's young age and family history of CKD.

 

The team reviewed current treatment guidelines for IgA vasculitis nephritis, including the use of glucocorticoids, mycophenolate mofetil, and other immunosuppressive agents. They also discussed the importance of considering genetic factors in this patient's presentation, given his brother's diagnosis of FSGS and a pathogenic variant in the CD2AP gene. The conversation ended with discussions about follow-up management and the potential need for additional genetic testing to understand the underlying cause of the patient's disease.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Hayder Aledan, Dr.Alaa Abbas , Dr. Dua’a Knehir (Organizer), Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. kawa, Dr. Mustafa Abdullah, Dr. Zainab, Dr Ali Ahmed Alemara, Dr. Hassan Hazem, Dr. Wael Mohan, Dr.Noor Sadiq, Dr. Sima Salar, Dr. Sana Othman, Dr. Khoshe, Dr. Ahang M. Ghafoor (AMG), Dr. Lona Abdullah, Dr. Meer ahmad, Dr.Ali wafi, Dr.Ali Abdul Muhsin, Dr.Ali, Dr. Mustafa Abdullah, Dr. Hayder hasan, د. زهراء محمد علي

​

​

​

12th September 2026

The meeting focused on a case-based nephrology and internal medicine teaching session.

  • The group reviewed a complex case of light-chain crystalline podocytopathy (LCCP) and tubulopathy in a kidney transplant recipient with monoclonal gammopathy, discussing the diagnostic challenges, the role of electron microscopy, and the response to clone-directed immunochemotherapy.

  • The participants also discussed several clinical vignettes covering acute decompensated heart failure and diuretic management.

  • A case of gout in CKD and the appropriate use of allopurinol.

  • A case of hypokalemia in a young woman with asthma, attributing it to albuterol use. The session included explanations of pathophysiology, interpretation of lab and imaging findings, and evidence-based management approaches.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaaey, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr. Hassan Al-Fatlawi, Dr. Sana Othman, Dr. Ali, Dr.  Ali Abdul Muhsin, Dr.Marwan, Dr. Jasem Saloom, Dr. Khoshe, Dr. Noor, Dr.Marwan, Dr. Mohammed Aqeel, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Wael Mohan, Dr. Mustafa Abdullah, Dr. Sham Sarheed, Dr. Haider Hasan, Dr. Noor Sadiq,Dr. Ali,Dr. Hassan Hazem,Dr. Jasem Saloom

 

 

 

 

 

 

​

5th September 2026

  • Dr. Shiraz presented a case ( supervised by Dr. Kais AlTaee ) of a 55-year-old male renal transplant recipient with progressive renal function decline over the past two years. The patient had a history of poor medication adherence and had multiple comorbidities including diabetes and hypertension.The group reviewed investigations, imaging studies and multiple slides of renal biopsy images by Dr. Shiraz and Dr. Alaa Abbas.The team observed various findings leading to non-lupus full house nephropathy and discussed lines of treatment and follow up.

  • The team discussed the treatment approach for a patient presenting with features of both diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)

  • They also addressed a case of a patient experiencing chest pain during hemodialysis, determining it was likely a type B dialyzer reaction and agreeing that the appropriate next step was to continue hemodialysis with close symptom monitoring rather than discontinuing treatment or changing to a cellulose-based membrane.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaaey, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr. Hassan Al-Fatlawi, Dr. Sana Othman, Dr. Mohammed Sami, Dr. Alaa Abbas Ali ,Dr. Mohammed Aqeel, Dr. Ali, Dr.  Ali Abdul Muhsin, Dr.Marwan, Dr. Jasem Saloom, Dr. Khoshe, Dr. Noor, Dr.Marwan, Dr. Mohammed Aqeel, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Wael Mohan, Dr. Mustafa Abdullah, Dr. Sham Sarheed, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr.shiraz, Dr.Hassan Hazem, Dr.Zaid Aldabbagh,Dr. Noor, Dr. Sima Salar, Dr. Ahmed Hadi

 

 

 

 

29th August 2026

  • Dr. Mohammad Ali presented a case ( supervised by Dr. Ibrahim Assi ) of a young man with recurrent calcium oxalate nephrolithiasis, hypomagnesemia, hypokalemia, and strong family history of kidney stones and CKD, which was discussed as likely familial hypomagnesemia with hypercalciuria and nephrocalcinosis, and later confirmed by genetic testing as primary hyperoxaluria type 3 (HOGA1 gene). The group reviewed the clinical features, differential diagnosis, genetic testing, and management options, and the role of liver–kidney transplantation.

  • Dr. Hayder Aledan shared data from a Chinese study using whole exome sequencing in pediatric nephrolithiasis, emphasizing the yield of genetic diagnosis in severe or recurrent cases.

  • The team presented questions on secondary hyperparathyroidism in CKD and phosphate binders.

  • Also case of  preeclampsia with severe proteinuria and hypertension in pregnancy and indications of urgent delivery.

  • Management of severe hyponatremia in a cirrhotic patient on CRRT and the principles of sodium correction in CRRT.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaaey, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr. Sana Othman, Dr. Alaa Abbas Ali ,Dr. Mohammed Aqeel, Dr. Ali Abdul Muhsin, Dr. Jasem Saloom, Dr. Khoshe, Dr.Marwan, Dr. Mohammed Aqeel, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Wael Mohan, Dr. Mustafa Abdullah, Dr. Shahad AbdulAzeez, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Mustafa Abdullah, Dr.Hassan Al-Fatlawi,Dr.Noor Sadiq, Dr.Sagvan Kocher, Dr. Athal Jassem, Dr.Hassan Hazem, Dr.Mustafa Abdullah, Dr. Zainab, Dr. Leith Al Zubaidy, Dr.Shiraz

 

 

 

22nd August 2026

The team discussed clinical cases related to transplant patients from a journal.

  • For the first case involving a 33-year-old woman with a history of atypical sarcoma and positive HPV,the patient should be listed for transplant with enhanced cervical cancer screening every 6 months to a year post-transplant.

  • For the second case involving a 68-year-old man with recurrent skin cancer after kidney transplant, they agreed that converting tacrolimus to sirolimus, as sirolimus has a lower risk of non-melanoma skin cancer compared to other immunosuppressants.

  • Case about Post-Transplant Immunosuppression Management Strategies

  • Multiple Myeloma Treatment Discussion

  • Another clinical cases discussion :

The participants reviewed several clinical scenarios, including a patient with C3 glomerulonephritis where they discussed treatment options and the importance of complement pathway testing.

They also examined management approaches for patients with acute ischemic stroke regarding blood pressure control and for a patient in septic shock requiring renal replacement therapy.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaaey, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer),Dr. Dua’a Nabeel,Dr. Hassan Al-Fatlawi, Dr. Sana Othman, Dr. Alaa Abbas Ali ,Dr. Mohammed Aqeel, Dr.  Ali Abdul Muhsin, Dr. Khoshe,Dr. Shahad AbdulAzeez, Dr.Marwan, Dr. Mohammed Aqeel, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Aseel, Dr. Wael Mohan, Dr. Mustafa Abdullah, Dr. Sham Sarheed, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Zainab,Dr. Khoshe, Dr. Mustafa Abdullah, Dr. Hassan Hazem, Dr. Jasem Saloom, Dr. Ali

 

 

 

 

 

​

15th August 2026

  • The meeting focused on a case presentation by Dr. Wael Mohan ( supervised by Dr. Hasanain Alkhammas ) and discussion of a 37-year-old male patient with severe renal failure, hemoptysis, and a history of constitutional symptoms, leading to a diagnosis of ANCA-associated vasculitis with renal involvement. Wael presented the clinical details, investigations, and biopsy findings. The group discussed the differential diagnosis, emphasizing vasculitis and the role of ANCA serology, and reviewed the management approach.

Dr. Alaa explained the biopsy findings, highlighting extensive necrosis and fibrinoid changes. The participants debated the indications for continuing plasma exchange and cyclophosphamide, considering the patient's persistent dialysis dependence and the destructive nature of the renal biopsy.

Guidelines for the management of ANCA-associated vasculitis were reviewed, including induction and maintenance therapies, and the importance of early treatment was stressed. The discussion also touched on the role of rituximab as an alternative to cyclophosphamide for maintenance and the need for prophylaxis against infections.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibraheem Assi, Dr. Dua’a Knehir (Organizer), Dr. Wael Mohan, Dr. Alaa Abbas Ali, Dr. Hassan Al-Fatlawi, Dr. Sana Othman, Dr. Mohammed Sami,Dr. Mohammed Aqeel, Dr. Ali, Dr. Dua’a Nabeel, Dr. Ali Abdul Muhsin, Dr.Marwan, Dr. Ahmed Hadi , Dr. Khoshe, Dr. Noor Sadiq, Dr. Mohammed Aqeel, Dr. Taman Mahdi, Dr. Ridha Alshawy, , Dr. Mustafa Abdullah, Dr. Shahad AbdulAzeez, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Ali Wafi, Dr. Aseel, Dr. Hussein Al-Moussawi, Dr Lana Adel ,Dr. Jasem Saloom, Dr. Sima Salar, Dr. Jwad Amjed Anwar, Dr. Sana Othman

 

 

 

 

1st August 2026

This meeting was a medical case presentation and discussion session focused on renal pathology.

  • Dr. Mohammed ( under supervision of Dr. Ibrahim Assi ) presented a case of a 26-year-old female teacher who developed symptoms of azotemia and headache over 5 weeks, initially diagnosed with gastritis but later found to have severe kidney dysfunction with nephrotic-range proteinuria. The team discussed the patient's clinical presentation, laboratory findings, and renal biopsy results which showed chronic thrombotic microangiopathy (TMA) with global and segmental glomerulosclerosis involving 92% of glomeruli and interstitial fibrosis. The group extensively debated differential diagnoses and the need for genetic testing to confirm atypical hemolytic uremic syndrome.

¨The group discussed medical exam questions related to Staphylococcus-associated infection-related glomerulonephritis, IgA nephropathy, and Granulomatosis with Polyangiitis (GPA).

¨Dialysate Sodium Adjustment Discussion

The team discussed treatment adjustments for a patient with high intra-dialytic weight gain, agreeing that the most appropriate next step is to decrease the dialysate sodium concentration rather than increasing blood flow or changing medications.

  • Hypomagnesemia Treatment Management Discussion

The group discussed the management of hypomagnesemia, focusing on appropriate treatment options. They identified that for patients with renal magnesium wasting, amiloride is the recommended treatment as it increases magnesium reabsorption in the collecting duct.

  • Hypokalemia in Peritoneal Dialysis Patient

The meeting focused on discussing a case of hypokalemia in a patient receiving peritoneal dialysis. The group analyzed potential causes, including dialytic loss, transcellular shift, potassium restricted diet, and gastrointestinal loss.

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr. Mohammed Aqeel, Dr. Wael Mohan, Dr. Alaa Abbas Ali, Dr. Hassan Al-Fatlawi, Dr. Shahad AbdulAzeez, Dr. Ali Abdul Muhsin, Dr. Ahmed Hadi , Dr. Khoshe, Dr. Noor Sadiq, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Mustafa Abdullah, Dr. Duaa Nabeel, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Zaid Aldabbagh, Dr. Sana Osman, Dr. Jasem Saloom, Dr. Ali Wafi, Dr. Nawaf Al-Neaimy, Dr. Zainab, Dr. Marwan

​

​

​

​

25th July 2026

  • The meeting focused on a case presentation by Dr. Duaa Knehir ( supervised by Dr.Mohammed AlAtbi ) of a 38-year-old male athletic patient who presented with vomiting and epigastric pain for two weeks. The patient was initially treated with IV fluids and medications before being referred to the nephrology department due to hypokalemia and hypomagnesemia. The discussion included the patient's clinical findings, laboratory results, and the reason for referral to nephrology, with participants asking questions about the patient's history and potential causes of the electrolyte disturbances, with diagnosis of high-dose vitamin D use.

  • Kidney Transplant Infection Management

A patient with a kidney transplant who developed an emphysematous urinoma, a rare gas-forming infection. The group agreed that surgical exploration and repair of the urine leak was the most appropriate treatment approach.

  • Rhabdomyolysis case discussion

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr.Bnar, Dr.Duaa Nabeel, Dr. Mohammed Aqeel, Dr. Wael Mohan, Dr. Alaa Abbas Ali,Dr.Lana Adil, Dr. Hassan Al-Fatlawi, Dr. Shahad AbdulAzeez, Dr. Mohammed Sami, Dr. Ahmed Hadi , Dr. Khoshe, Dr. Noor Sadiq, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Aseel, Dr. Duaa Nabeel, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Ali Wafi ,Dr.Marwan, Dr. Forat Tareq, Dr.Sima Salar, Dr. Bnar Sardar,Dr. Zainab, Dr.Mohammed A Mahmood, Dr. Nawaf Al-Neaimy,Dr. Ali, Dr.Dlnya Asad, Dr.Jwad Amjed Anwar, Dr.Sana Othman, Dr. Zaid Aldabbagh

 

 

 

 

 

 

 

​

18th July 2026

The team discussed a case from a journal of a patient finally diagnosed with SLE-Myopathy overlap syndrome.

  • The patient's condition progressed through three phases: initial Raynaud phenomenon and vaginal bleeding, followed by systemic symptoms and immune system activation, and finally an emergency presentation with fibroid-related hemorrhage requiring transfusions. The team discussed potential diagnoses for a patient, considering conditions such as cancer, infection, SLE, mixed connective tissue disease, and dermatomyositis. Several participants suggested that the patient's symptoms, including muscle weakness, alopecia, cardiac involvement, and interstitial lung process, were most consistent with an autoimmune disease, particularly systemic lupus erythematosus (SLE).

 SLE-Myopathy Overlap Syndrome Discussion

The team discussed a case of an overlap syndrome involving systemic lupus erythematosus (SLE) and idiopathic inflammatory myopathy. The patient's electromyography revealed changes suggestive of inflammatory myopathy, and she was diagnosed based on clinical features, test results, and specific antibodies. Treatment with intravenous immunoglobulin instead of steroids was initiated, leading to improved muscle strength and other clinical improvements.

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr.Bnar, Dr.Duaa Nabeel, Dr. Mohammed Aqeel, Dr. Wael Mohan, Dr. Alaa Abbas Ali,Dr.Lana Adil, Dr. Hassan Al-Fatlawi, Dr. Shahad AbdulAzeez, Dr. Mohammed Sami, Dr. Ahmed Hadi , Dr. Khoshe, Dr. Noor Sadiq, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Aseel, Dr. Duaa Nabeel, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Ali Wafi, Dr. Zaid Aldabbagh, Dr. Abdullah Touma, Dr.Jwad Amjed Anwar, Dr. Zainab, Dr. Ayob Alaurebi, Dr. Jasem Saloom, Dr. Nawaf Al-Neaimy.

 

​

​

​

​

11th July 2026

  • The team discussed a patient ( case from a journal ) with IgA vasculitis, cryoglobulinemic vasculitis, and new-onset systemic lupus erythematosus. They examined the patient's complement levels, noting undetectable C4 and mildly low C3, which led them to exclude diagnoses like ANCA-associated vasculitis, anti-GB glomerular basement membrane disease, and IgA vasculitis. Based on the patient's clinical presentation and complement profile, the team concluded that cryoglobulinemic vasculitis was the most likely diagnosis, particularly given the disproportionately low C4 level.

  • Waldenstrom Macroglobulinemia Treatment Discussion

The team discussed treatment approaches for a patient with Waldenstrom macroglobulinemia and cryoglobulinemia. They reviewed multiple therapeutic options including bortezomib, dexamethasone, and rituximab, as well as therapeutic plasma exchange and systemic glucocorticoids.

  • The discussion then shifted to a new clinical case involving a 58-year-old patient with hypertension, where the team considered various management options including renal artery duplex ultrasonography, repeating plasma renin activity and aldosterone concentration.

  • Acetaminophen to Lidocaine Patch Switch

The team discussed changing acetaminophen to a lidocaine patch for a patient with increased blood pressure after starting high-dose acetaminophen

  • IgA Nephropathy Treatment Discussion

The team discussed the management of a 28-year-old patient with IgA nephropathy who had completed a 9-month course of targeted-release budesonide. They determined that the next best step in treatment would be to change losartan to sparsentan, a dual endothelin and angiotensin receptor antagonist, as the patient is at high risk for progressive renal failure despite stable serum creatinine levels.

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr.Duaa Nabeel, Dr. Noor Sadiq Dr. Mohammed Aqeel, Dr. Wael Mohan, Dr. Aseel ,Dr. Alaa Abbas Ali, Dr. Hassan Al-Fatlawi, Dr. Shahad AbdulAzeez, Dr. Mohammed Sami, Dr. Khoshe, , Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Duaa Nabeel, Dr. Hayder Hasan, Dr.Ahmed Hadi, Dr. Ali Ahmed Alemara, Dr. Ali Wafi, Dr.halmat kamil, Dr.Mustafa Abdullah, Dr. Nawaf Al-Neaimy, Dr. Ali, Dr. Mustafa Abdullah

​

​

​

 

​

4 July 2026

  • This meeting was a nephrology case presentation and discussion session led by Dr. Zainab Saad Salem, supervised by Dr. Ibrahim Asse, focusing on a 38-year-old female patient with mixed connective tissue disease presenting with lupus nephritis. The patient had a history of rheumatoid arthritis and hypertension, developed lower limb and periorbital swelling after stopping her RA medication, and presented with proteinuria, elevated creatinine, and dilated cardiomyopathy.

The team reviewed the patient's clinical findings, laboratory results showing elevated renal indices and positive ANA, and kidney biopsy findings consistent with Class IV lupus nephritis with crescent formation. The discussion included differential diagnoses, treatment approaches with immunosuppressive agents and management strategies for this chronic kidney disease patient.

  • Lupus Nephritis Treatment Discussion

The team discussed the management of a 27-year-old woman with lupus nephritis who has not shown improvement despite 18 months of treatment with glucocorticoids, mycophenolate mofetil, and belimumab. The group agreed that the most appropriate next step is to repeat the kidney biopsy to assess for histopathological changes and evaluate for active versus chronic lesions

  • Kidney Transplant Candidacy Evaluation

The team discussed the kidney transplant candidacy of a 78-year-old man with end-stage kidney disease receiving hemodialysis. Due to multiple comorbidities including age, long-standing diabetes, vascular disease, obesity, and poor functional status, the consensus was that the patient is not a candidate for kidney transplantation. The group agreed that placing him on the waiting list is not recommended, as his risk of perioperative complications and poor outcomes outweighs any potential benefits, even if a suitable living donor were found.

  • Right Atrial Thrombus Management

The group discussed a case of a 62-year-old woman with end-stage kidney disease who presented with hypotension and fatigue. They identified a right atrial thrombus associated with her hemodialysis catheter as the most likely diagnosis, with the clinical presentation suggesting an infected thrombus

 

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr.Duaa Nabeel, Dr. Zainab Saad Salem, Dr.Ahmed Hadi , Dr. Mohammed Aqeel, Dr. Noor Sadiq, Dr. Alaa Abbas Ali, Dr. Shahad AbdulAzeez, Dr. Mohammed Sami, Dr. Khoshe, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Hayder Hasan, , Dr. Ali Ahmed Alemara, Dr. Aseel, Dr.Zainab Al-Haj Zubeer, Dr. Zainab, Dr.Mostafa thamer, Dr. Sima Salar, Dr. Blnd Al Naqshabandi, Dr. Mustafa Abdullah, Dr.Ali, Dr.Zaid Aldabbagh, Dr. Marwan

​

​

​

​

​

​

13th June 2026

  • The main case presented from a journal was a female patient with acute kidney injury, anemia, and heavy proteinuria who was suspected of having hemolytic uremic syndrome (HUS).

The patient showed improvement after receiving fresh frozen plasma and steroid treatment, but her creatinine level remained at 1.4 and there was still evidence of activity in her blood tests. The group discussed whether to perform a kidney biopsy to confirm the diagnosis and rule out secondary causes, with some participants suggesting that genetic testing for complement factor mutations could be helpful in determining the underlying cause.

  • The discussion also covered the role of plasma exchange and specific treatments for atypical HUS cases.

  • Additionally, the meeting included presentations of other clinical cases related to kidney disease, including discussions about lipoprotein glomerulopathy

  • L-carnitine deficiency in hemodialysis patients

  • Contrast-associated acute kidney injury prevention strategies.

 

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr.Ahmed Hadi, Dr. Mohammed Aqeel, Dr. Noor Sadiq, Dr. Alaa Abbas Ali, Dr. Shahad AbdulAzeez, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Hayder Hasan, , Dr. Ali Ahmed Alemara, Dr. Aseel, Dr.Duaa Nabeel, Dr. Khoshe, Dr. Dlnya Asad, Dr. Ali wafi, Dr.Ali, Dr. Wael Mohan, Dr. Hassan Al-Fatlawi, Dr. Sana Othman, Dr. Lana Adel, Dr. Hassan Hazem, Dr. Halmat Kamil.

 

 

 

 

 

​

6th June 2026

  • Dr. Mohanad presented a case study ( supervised by Dr. Ibrahim Assi ) of a 46-year-old female patient with nephrotic syndrome, elevated lipid levels, and a family history of renal disease. The discussion included detailed pathological findings from Dr. Alaa, who described the characteristic features of LPG under light and electron microscopy.

The team discussed the epidemiology, clinical features, and current treatment options for LPG, noting that while specific targeted therapies are lacking, lipid-lowering medications like fibrates and statins show promise in managing the condition. The group agreed that this case deserves publication to contribute to the limited literature on LPG.

  • Patient Calcium Level Diagnosis Discussion

The meeting discussed a patient case involving elevated serum calcium levels with discussion included reviewing various laboratory values and their implications for diagnosing the underlying cause of the patient's condition.

  • Hyperparathyroidism and Kidney Disease Discussion

  • The group discussed various aspects of hyperparathyroidism, including primary and secondary forms, as well as their association with chronic kidney disease (CKD) and other conditions.

  • Oxalate Nephropathy Treatment Discussion

The main medical discussion centered around a patient with oxalate nephropathy, cystic fibrosis, and kidney issues, with participants discussing treatment options including pyridoxine, cholestyramine, and pancreatic enzymes

 

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer), Dr. Zainab,Dr. Hassan Hazem, Dr. Wael Mohan, , Dr. Muhanad Mohammed, Dr.Ali, Dr_Abdulbary Abdulhaleem, DR. Halmat Kamil, Dr.Ahmed Hadi, Dr. Mohammed Aqeel, Dr. Noor Sadiq, Dr. Alaa Abbas Ali, Dr. Shahad AbdulAzeez, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Hayder Hasan, Dr. Ali Ahmed Alemara, Dr. Aseel, Dr.Duaa Nabeel, Dr. Khoshe, Dr. Sana Othman, Dr. Blnd Al Naqshabandi, Dr. Sima Salar, Dr. Herish Osman,Dr. Ali wafi, Dr. Ali Abdul Muhsin

 

 

 

​

23rd May 2026

  • The session included detailed discussions of a case presented by Dr. Mohammed ( supervised by Dr. Ibrahim Assi ) involving a 35-year-old woman with rheumatoid arthritis and nephrotic syndrome, which was reviewed with electron microscopy findings showing membranous nephropathy positive for phospholipase A2 receptor (PLA2R). The discussion also covered treatment approaches, including the use of cyclosporine and prednisolone, and the considerations for when to perform a kidney biopsy and initiate treatment based on clinical presentation and test results

  • Kidney Disease Treatment Management

The team discussed the management of a 52-year-old woman with end-stage kidney disease and anemia. They determined that increasing the dose of epoetin alpha was the most appropriate next step

  • Kidney Disease and Hypertension Management

The team discussed the management of a patient with stage 4 chronic kidney disease and uncontrolled hypertension.

  • The group also reviewed a case of severe hypertension in a young patient, concluding that renal angiography with angioplasty was the best approach to identify and potentially treat renal artery stenosis, which could be causing the hypertension.

 

Attendees:

Dr. Ihsan AlShamaa, Dr. Kais AlTaee, Dr. Hasanain Alkhammas, Dr. Saja Mahmoud, Dr. Hayder Aledan, Dr. Ibrahim Assi, Dr. Dua’a Knehir (Organizer),Dr. Mohammed Sami, Dr.Ahmed Hadi, Dr. Mohammed Aqeel, Dr. Noor Sadiq, Dr. Alaa Abbas Ali, Dr. Shahad AbdulAzeez, Dr. Taman Mahdi, Dr. Ridha Alshawy, Dr. Hayder Hasan, , Dr. Ali Ahmed Alemara, Dr. Aseel, Dr.Duaa Nabeel, Dr. Khoshe, Dr.Mustafa Abdullah, Dr. Sagvan, Dr. Zainab, Dr. Wael Mohan, Dr. halmat kamil, Dr. Hassan Al-Fatlawi, Dr. Sima Salar, Dr. Sana Othman, Dr. Mohanad Mohammed, Dr.Zaid Aldabbagh.

bottom of page